NVO
Novo-Nordisk A/S
stockNYSEADR
At CloseNov 6, 2026 3:59:59 PM EST
40.30USD0.000%(-0.00)9,236,760
Pre-marketNov 6, 2026 9:29:30 AM EST
39.77USD-1.315%(-0.53)
After-hoursNov 6, 2026 4:54:30 PM EST
40.32USD+0.050%(+0.02)
Loading…
Loading…
177.90B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$40.30
Beta
0.96
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$40.58
SMA 200
$43.70
Avg. Vol 10D
12.91M
Avg. Vol 30D
11.88M
Avg. Vol 90D
12.15M
Relative Vol
0.78
4.41B
3.15B
71.53%
37,436,108
1.18%
3.11
55%/45%
38.17%
24.35%
0.2800%
10,000,000
1,902
13,684
121,034
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
Nov 7, 2026
Novo Nordisk Just Delivered Great News for Investors. Is a Comeback Finally Underway? · 
The Motley Fool+1 source
Forget Lilly and Novo: Pfizer Is Planning a Wave of Phase 3 Obesity Trials · The Motley Fool+2 sources
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
NVO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 40.45 | 2026-11-02 | -0.25% | 1.301 |
| 1M | 38.18 | 2026-10-08 | +5.68% | 0.806 |
| 3M | 47.26 | 2026-08-07 | -14.63% | 0.569 |
| 6M | 46.07 | 2026-05-08 | -12.42% | 0.143 |
| 1Y | 45.68 | 2025-11-07 | -11.67% | 0.962 |
| 2Y | 107.20 | 2024-11-08 | -62.36% | — |
| 5Y | 57.35 | 2021-11-08 | -29.65% | 0.671 |
NVO Stock Summary
Novo-Nordisk A/S (NYSE:NVO) stock price today is $40.35, and today's volume is 9,236,760. The 30 day average volume is 11.88M. NVO market cap is $177.90B with 4.41B shares outstanding.